Varian Medical Systems Company Profile (NYSE:VAR)

About Varian Medical Systems (NYSE:VAR)

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

Industry, Sector and Symbol:

Sector: Medical
Industry: Advanced Medical Equipment & Technology
Sub-Industry: Health Care Equipment
Symbol: NYSE:VAR
CUSIP: 92220P10
Web: www.varian.com

Capitalization:

Market Cap: $9.65654 billion
Outstanding Shares: 91,800,000

Average Prices:

50 Day Moving Avg: $102.10
200 Day Moving Avg: $97.84
52 Week Range: $75.20 - $107.87

P/E:

Trailing P/E Ratio: 34.62
Foreward P/E Ratio: 24.02
P/E Growth: 2.66

Sales & Book Value:

Annual Revenue: $3.27 billion
Price / Sales: 2.95
Book Value: $15.16 per share
Price / Book: 6.94

Profitability:

EBIDTA: $643 million
Net Margins: 9.50%
Return on Equity: 24.70%
Return on Assets: 11.12%

Debt:

Debt-to-Equity Ratio: 0.18%
Current Ratio: 1.62%
Quick Ratio: 1.26%

Misc:

Average Volume: 776,103 shs.
Beta: 0.58
Short Ratio: 7.65

Frequently Asked Questions for Varian Medical Systems (NYSE:VAR)

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) issued its earnings results on Wednesday, July, 26th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.95 by $0.09. The business earned $662.40 million during the quarter, compared to analysts' expectations of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company's revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.00 EPS. View Varian Medical Systems' Earnings History.

When will Varian Medical Systems make its next earnings announcement?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems issued an update on its fourth quarter earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $1.15-$1.23 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.18.

Where is Varian Medical Systems' stock going? Where will Varian Medical Systems' stock price be in 2017?

10 brokers have issued 1 year target prices for Varian Medical Systems' stock. Their predictions range from $81.50 to $106.00. On average, they anticipate Varian Medical Systems' share price to reach $94.94 in the next twelve months. View Analyst Ratings for Varian Medical Systems.

What are analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:

1. According to Zacks Investment Research, "Varian Medical's oncology and Proton therapy business growth prospects remain impressive. The company is addressing both the tier 1 and mid-tier markets through its Edge, Truebeam and VitalBeam, Halcyon products. Varian has been winning contracts, not only in the Americas but also in the emerging international markets, which is a huge positive. We believe China and Africa present significant top-line growth opportunity in the near term. The company is opening up new offices in Africa and the Middle East, which shows that it is aware of the growth opportunities in the region. Varian Medical posted an impressive second quarter of fiscal 2017, beating the Zacks Consensus Estimate on both the counts. The company’s upbeat guidance for the coming quarters is a positive. Share price movement in the past three months has been encouraging, trading above the broader industry." (7/13/2017)
2. Jefferies Group LLC analysts commented, "We hosted VAR CEO and CFO for a lunch. Key takeaways: 1) VREX spin process was all inclusive; 2) F17 RemainCo outlook calls for HSD EPS growth; 3) RadOnc outlook stable on multiple fronts near and long-term; 3) next-gen linac expected in 2H17; 5) aim is to double Software in 5-years; 6) proton stable postCTCL with glimmers of light in tunnel; and 7) at least $1.0bn in debt capacity for M&A. We are publishing revised stand-alone estimates and PT of $88." (2/8/2017)

Who are some of Varian Medical Systems' key competitors?

Some companies that are related to Varian Medical Systems include Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR), Quidel Corporation (QDEL), Accelerate Diagnostics (AXDX), Mazor Robotics (MZOR), Natus Medical Incorporated (BABY), ABAXIS (ABAX), Luminex Corporation (LMNX), LeMaitre Vascular (LMAT), Pacific Biosciences of California (PACB), GenMark Diagnostics (GNMK), Accuray Incorporated (ARAY) and ViewRay (VRAY).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:

R. Andrew Eckert, Independent Chairman of the Board
Dow R. Wilson, President, Chief Executive Officer
Timothy E. Guertin, Vice Chairman of the Board
Elisha W. Finney, Chief Financial Officer, Executive Vice President - Finance
Gary E. Bischoping Jr., Chief Financial Officer
Kolleen T. Kennedy, Executive Vice President and President - Oncology Systems
John W. Kuo, Senior Vice President, General Counsel, Corporate Secretary
Rafael Torres, Senior Vice President - Business Development and Strategy
Jose Baselga M.D., Ph.D., Director
Jean-Luc Butel, Director

Who owns Varian Medical Systems stock?

Varian Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.99%), BlackRock Inc. (9.19%), First Eagle Investment Management LLC (5.10%), State Street Corp (4.60%), Janus Henderson Group PLC (4.09%) and Alecta Pensionsforsakring Omsesidigt (3.09%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, R Andrew Eckert, Ruediger Naumann-Etienne, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Who sold Varian Medical Systems stock? Who is selling Varian Medical Systems stock?

Varian Medical Systems' stock was sold by a variety of institutional investors in the last quarter, including Fairpointe Capital LLC, Anchor Capital Advisors LLC, New York State Common Retirement Fund, Atlanta Capital Management Co. L L C, Swiss National Bank, First Trust Advisors LP, Quantitative Investment Management LLC and Van ECK Associates Corp. Company insiders that have sold Varian Medical Systems stock in the last year include Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Who bought Varian Medical Systems stock? Who is buying Varian Medical Systems stock?

Varian Medical Systems' stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Koch Industries Inc., Arrowstreet Capital Limited Partnership, York Capital Management Global Advisors LLC, BlackRock Inc., Parametric Portfolio Associates LLC, Gotham Asset Management LLC and FMR LLC. View Insider Buying and Selling for Varian Medical Systems.

How do I buy Varian Medical Systems stock?

Shares of Varian Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of Varian Medical Systems stock can currently be purchased for approximately $105.19.

MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		326 (Vote Outperform)
Underperform Votes:		297 (Vote Underperform)
Total Votes:		623

MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Varian Medical Systems (NYSE:VAR) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	2 Sell Ratings, 6 Hold Ratings, 2 Buy Ratings
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$94.94 (9.75% downside)

Analysts' Ratings History for Varian Medical Systems (NYSE:VAR)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
9/7/2017	BTIG Research	Downgrade	Buy -> Neutral		Medium
9/1/2017	Royal Bank Of Canada	Reiterated Rating	Hold	$100.00	N/A
8/28/2017	Robert W. Baird	Reiterated Rating	Hold	$99.00	Low
5/17/2017	Aegis	Reiterated Rating	Hold	$91.00	Low
5/16/2017	Goldman Sachs Group, Inc. (The)	Initiated Coverage	Neutral -> Neutral	$92.00	Low
5/15/2017	Citigroup Inc.	Upgrade	Neutral -> Buy		Low
5/11/2017	Jefferies Group LLC	Reiterated Rating	Buy		Low
4/27/2017	Barrington Research	Downgrade	Outperform -> Market Perform		High
4/24/2017	Off Wall Street	Initiated Coverage	Sell		Low
1/26/2017	Evercore ISI	Downgrade	Hold -> Sell	$81.50	N/A
7/28/2016	Morgan Stanley	Boost Price Target	Underweight	$80.00 -> $86.00	N/A
7/28/2016	Brean Capital	Boost Price Target	Buy	$87.00 -> $90.00	N/A
10/20/2015	J P Morgan Chase & Co	Reiterated Rating	Neutral	$95.00 -> $75.00	N/A

(Data available from 9/25/2015 forward)

Earnings History for Varian Medical Systems (NYSE:VAR)

Earnings by Quarter for Varian Medical Systems (NYSE:VAR)

Earnings History by Quarter for Varian Medical Systems (NYSE VAR)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/24/2017		$1.19					N/A
7/26/2017	Q3 2017	$0.95	$1.04	$663.86 million	$662.40 million	View	N/A
4/26/2017	Q2 2017	$0.88	$0.89	$639.26 million	$655.00 million	View	N/A
10/26/2016	Q4112	$1.34	$1.38	$880.29 million	$912.00 million	View	Listen
7/27/2016	Q316	$1.17	$1.22	$779.90 million	$789.40 million	View	Listen
4/27/2016	Q216	$1.08	$1.09	$769.56 million	$758.80 million	View	Listen
1/27/2016	Q116	$0.94	$0.99	$748.01 million	$757.00 million	View	Listen
10/28/2015	Q4	$1.10	$1.04	$813.18 million	$817.80 million	View	Listen
7/29/2015	Q3	$1.10	$1.13	$810.41 million	$784.00 million	View	Listen
4/29/2015	Q215	$1.00	$1.05	$799.66 million	$759.40 million	View	N/A
1/28/2015	Q115	$0.87	$0.99	$720.83 million	$737.90 million	View	N/A
10/22/2014	Q415	$1.21	$1.02	$837.86 million	$812.10 million	View	Listen
7/23/2014	Q314	$1.09	$1.08	$767.52 million	$747.70 million	View	N/A
4/23/2014	Q4112	$1.03	$1.04	$772.84 million	$779.00 million	View	N/A
1/22/2014	Q3112	$0.90	$0.91	$718.23 million	$712.00 million	View	N/A
10/23/2013	Q3112	$1.12	$1.08	$779.02 million	$770.00 million	View	N/A
7/24/2013	Q3 2013	$1.01	$1.03	$749.01 million	$726.20 million	View	N/A
4/24/2013	Q2 2013	$1.02	$1.04	$758.02 million	$768.40 million	View	N/A
1/23/2013	Q1 2013	$0.87	$0.86	$676.15 million	$678.40 million	View	N/A
10/25/2012		$1.03	$1.08			View	N/A
7/25/2012		$0.94	$0.96			View	N/A
4/25/2012		$0.96	$0.96			View	N/A
1/25/2012		$0.75	$0.79			View	N/A
10/27/2011		$0.97	$0.95			View	N/A
7/27/2011		$0.83	$0.83			View	N/A
4/27/2011		$0.85	$0.86			View	N/A
1/26/2011		$0.73	$0.80			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Varian Medical Systems (NYSE:VAR)

2017 EPS Consensus Estimate: $4.18
2018 EPS Consensus Estimate: $4.43

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	2	$1.04	$1.06	$1.05
Q2 2017	2	$0.91	$1.08	$1.00
Q3 2017	2	$0.94	$0.95	$0.95
Q4 2017	2	$1.17	$1.20	$1.19
Q1 2018	2	$0.93	$1.07	$1.00
Q2 2018	2	$1.02	$1.03	$1.03
Q3 2018	2	$1.07	$1.14	$1.11
Q4 2018	2	$1.26	$1.33	$1.30

(Data provided by Zacks Investment Research)

Dividend History for Varian Medical Systems (NYSE:VAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Varian Medical Systems (NYSE:VAR)

Insider Ownership Percentage: 0.91%
Institutional Ownership Percentage: 99.28%

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/13/2017	Kolleen T Kennedy	EVP	Sell	933	$107.29	$100,101.57
9/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$107.33	$116,775.04
9/7/2017	Dow R Wilson	Insider	Sell	15,059	$105.41	$1,587,369.19
8/31/2017	Kolleen T Kennedy	EVP	Sell	931	$105.00	$97,755.00
8/14/2017	Kolleen T Kennedy	EVP	Sell	1,088	$97.91	$106,526.08
8/7/2017	Dow R Wilson	Insider	Sell	15,059	$96.48	$1,452,892.32
7/13/2017	John W Kuo	SVP	Sell	1,597	$104.43	$166,774.71
7/13/2017	Kolleen T Kennedy	EVP	Sell	2,021	$104.73	$211,659.33
7/12/2017	John W Kuo	SVP	Sell	863	$104.48	$90,166.24
7/12/2017	Kolleen T Kennedy	EVP	Sell	1,088	$104.49	$113,685.12
7/10/2017	Dow R Wilson	Insider	Sell	15,060	$103.37	$1,556,752.20
6/20/2017	Kolleen T Kennedy	EVP	Sell	26,092	$105.00	$2,739,660.00
6/13/2017	John W Kuo	SVP	Sell	734	$101.91	$74,801.94
6/12/2017	John W Kuo	SVP	Sell	863	$101.25	$87,378.75
6/12/2017	Kolleen T Kennedy	EVP	Sell	1,087	$101.20	$110,004.40
6/9/2017	Timothy E Guertin	Director	Sell	16,000	$103.22	$1,651,520.00
6/8/2017	Mark R Laret	Director	Sell	1,428	$103.47	$147,755.16
6/1/2017	Kolleen T Kennedy	EVP	Sell	56,573	$99.76	$5,643,722.48
5/31/2017	John W Kuo	SVP	Sell	19,819	$99.67	$1,975,359.73
5/12/2017	John W Kuo	SVP	Sell	862	$96.39	$83,088.18
5/2/2017	Susan L Bostrom	Director	Sell	3,589	$91.08	$326,886.12
4/12/2017	John W Kuo	SVP	Sell	864	$89.74	$77,535.36
3/17/2017	John W Kuo	SVP	Sell	3,876	$91.75	$355,623.00
3/13/2017	John W Kuo	SVP	Sell	862	$87.89	$75,761.18
3/1/2017	John W Kuo	SVP	Sell	10,353	$84.81	$878,037.93
1/5/2017	Dow R Wilson	Insider	Sell	13,334	$88.74	$1,183,259.16
12/8/2016	John W Kuo	SVP	Sell	1,267	$90.33	$114,448.11
12/5/2016	Dow R Wilson	Insider	Sell	10,000	$90.03	$900,300.00
11/7/2016	Dow R Wilson	Insider	Sell	10,000	$90.59	$905,900.00
10/31/2016	Timothy E Guertin	Director	Sell	4,000	$90.32	$361,280.00
10/20/2016	John W Kuo	SVP	Sell	21,266	$103.70	$2,205,284.20
10/5/2016	Dow R Wilson	Insider	Sell	10,000	$99.44	$994,400.00
10/3/2016	Elisha W Finney	CFO	Sell	4,668	$98.87	$461,525.16
9/15/2016	John W Kuo	SVP	Sell	4,073	$95.47	$388,849.31
9/7/2016	Elisha W Finney	CFO	Sell	9,000	$96.95	$872,550.00
9/6/2016	Dow R Wilson	Insider	Sell	10,000	$96.08	$960,800.00
9/1/2016	Elisha W Finney	CFO	Sell	2,000	$95.82	$191,640.00
8/5/2016	Dow R Wilson	Insider	Sell	10,000	$95.14	$951,400.00
8/1/2016	Clarence R Verhoef	SVP	Sell	9,483	$94.88	$899,747.04
8/1/2016	Elisha W Finney	CFO	Sell	25,334	$94.90	$2,404,196.60
8/1/2016	Timothy E. Guertin	Director	Sell	4,000	$94.88	$379,520.00
7/5/2016	Dow R Wilson	CEO	Sell	10,000	$82.08	$820,800.00
6/27/2016	Dow R Wilson	CEO	Sell	10,000	$78.27	$782,700.00
6/8/2016	Ruediger Naumann-Etienne	Director	Sell	1,000	$84.83	$84,830.00
6/3/2016	Mark R Laret	Director	Sell	1,545	$83.48	$128,976.60
5/2/2016	Timothy E. Guertin	Director	Sell	4,000	$81.55	$326,200.00
4/20/2016	Elisha W Finney	CFO	Sell	4,000	$85.95	$343,800.00
4/18/2016	Clarence R Verhoef	SVP	Sell	2,500	$85.00	$212,500.00
3/23/2016	Dow R Wilson	CEO	Sell	45,650	$78.86	$3,599,959.00
3/10/2016	Ruediger Naumann-Etienne	Director	Sell	428	$77.99	$33,379.72
3/7/2016	Timothy E. Guertin	Director	Sell	4,000	$79.47	$317,880.00
2/17/2016	Elisha W. Finney	CFO	Sell	2,454	$78.59	$192,859.86
12/7/2015	Dow R. Wilson	CEO	Sell	9,000	$80.00	$720,000.00
12/2/2015	R Andrew Eckert	Director	Sell	3,000	$81.67	$245,010.00
11/24/2015	Elisha W. Finney	CFO	Sell	2,334	$80.90	$188,820.60
11/6/2015	Dow R. Wilson	CEO	Sell	18,000	$80.26	$1,444,680.00
9/8/2015	Dow R. Wilson	CEO	Sell	9,000	$80.05	$720,450.00
7/6/2015	Dow R Wilson	CEO	Sell	9,000	$85.80	$772,200.00
7/2/2015	Elisha W Finney	CFO	Sell	2,000	$85.95	$171,900.00
7/1/2015	Timothy E Guertin	Director	Sell	25,000	$84.20	$2,105,000.00
6/5/2015	Dow R Wilson	CEO	Sell	9,000	$86.29	$776,610.00
6/1/2015	Elisha W Finney	CFO	Sell	2,000	$85.99	$171,980.00
6/1/2015	Timothy E Guertin	Director	Sell	25,000	$86.08	$2,152,000.00
5/6/2015	Dow R Wilson	CEO	Sell	9,000	$86.64	$779,760.00
4/17/2015	Dow R Wilson	CEO	Sell	18,760	$93.63	$1,756,498.80
4/1/2015	Elisha W Finney	CFO	Sell	5,000	$92.76	$463,800.00
4/1/2015	Timothy E Guertin	Director	Sell	25,000	$92.76	$2,319,000.00
3/20/2015	Dow R Wilson	CEO	Sell	18,759	$94.44	$1,771,599.96
3/16/2015	Kolleen T Kennedy	EVP	Sell	1,972	$95.00	$187,340.00
3/6/2015	Timothy E Guertin	Director	Sell	4,000	$93.50	$374,000.00
3/2/2015	Elisha W Finney	CFO	Sell	5,000	$93.44	$467,200.00
3/2/2015	Timothy E Guertin	Director	Sell	50,000	$93.48	$4,674,000.00
2/23/2015	Elisha W Finney	CFO	Sell	1,326	$92.97	$123,278.22
2/10/2015	Mark R Laret	Director	Sell	10,000	$92.32	$923,200.00
2/3/2015	Venkatraman Thyagarajan	Director	Sell	10,000	$92.71	$927,100.00
2/2/2015	Dow R Wilson	CEO	Sell	60,000	$91.78	$5,506,800.00
2/2/2015	Elisha W Finney	CFO	Sell	6,667	$91.79	$611,963.93
2/2/2015	John W Kuo	SVP	Sell	3,490	$92.04	$321,219.60
2/2/2015	Ruediger Naumann-Etienne	Director	Sell	10,000	$91.87	$918,700.00
1/5/2015	Timothy E Guertin	Director	Sell	50,000	$86.27	$4,313,500.00
1/2/2015	Elisha W Finney	CFO	Sell	15,000	$87.05	$1,305,750.00
12/11/2014	Timothy E Guertin	Director	Sell	105,000	$86.67	$9,100,350.00
12/1/2014	Elisha W Finney	CFO	Sell	21,000	$88.72	$1,863,120.00
11/24/2014	Elisha W Finney	CFO	Sell	2,930	$88.24	$258,543.20
11/17/2014	Elisha W Finney	CFO	Sell	1,837	$87.71	$161,123.27
11/11/2014	Kolleen T Kennedy	SVP	Sell	1,242	$85.79	$106,551.18
11/10/2014	Ruediger Naumann-Etienne	Director	Sell	5,000	$85.31	$426,550.00
11/3/2014	Elisha W Finney	CFO	Sell	25,000	$83.82	$2,095,500.00
11/3/2014	Timothy E Guertin	Director	Sell	80,000	$83.72	$6,697,600.00
10/29/2014	Elisha W Finney	CFO	Sell	10,000	$83.95	$839,500.00
10/27/2014	Kolleen T Kennedy	SVP	Sell	1,240	$81.00	$100,440.00
10/1/2014	Elisha W Finney	CFO	Sell	15,000	$79.98	$1,199,700.00
9/11/2014	John W Kuo	SVP	Sell	605	$85.82	$51,921.10
9/2/2014	Elisha W Finney	CFO	Sell	20,000	$85.18	$1,703,600.00
8/20/2014	Venkatraman Thyagarajan	Director	Sell	5,000	$84.25	$421,250.00
8/7/2014	Elisha W Finney	CFO	Sell	5,000	$83.95	$419,750.00
8/1/2014	Elisha W Finney	CFO	Sell	15,000	$81.66	$1,224,900.00
8/1/2014	Timothy E Guertin	Director	Sell	80,000	$81.69	$6,535,200.00
7/9/2014	John W Kuo	SVP	Sell	582	$85.00	$49,470.00
7/1/2014	Elisha W Finney	CFO	Sell	20,000	$83.86	$1,677,200.00
6/23/2014	John W Kuo	SVP	Sell	1,745	$85.00	$148,325.00
6/16/2014	Kolleen T Kennedy	SVP	Sell	1,416	$82.42	$116,706.72
6/2/2014	Elisha W Finney	CFO	Sell	10,000	$82.35	$823,500.00
5/12/2014	Kolleen Kennedy	SVP	Sell	1,417	$81.96	$116,137.32
5/1/2014	Elisha Finney	CFO	Sell	10,000	$78.99	$789,900.00
5/1/2014	Timothy Guertin	Director	Sell	80,000	$78.98	$6,318,400.00
4/11/2014	Kolleen T Kennedy	SVP	Sell	640	$72.15	$46,176.00
4/1/2014	Elisha Finney	CFO	Sell	10,000	$83.97	$839,700.00
3/17/2014	Clarence Verhoef	SVP	Sell	1,140	$84.70	$96,558.00
3/11/2014	Kolleen Kennedy	SVP	Sell	1,417	$84.39	$119,580.63
3/10/2014	Timothy Guertin	Director	Sell	80,000	$84.05	$6,724,000.00
3/3/2014	Elisha Finney	CFO	Sell	10,000	$83.41	$834,100.00
2/21/2014	Mark Laret	Director	Sell	1,411	$84.06	$118,608.66
2/11/2014	Kolleen Kennedy	SVP	Sell	1,416	$80.59	$114,115.44
2/10/2014	R Andrew Eckert	Director	Sell	5,887	$80.52	$474,021.24
2/3/2014	Elisha Finney	CFO	Sell	10,000	$79.34	$793,400.00
2/3/2014	Timothy Guertin	Director	Sell	27,000	$79.34	$2,142,180.00
1/31/2014	Susan Bostrom	Director	Sell	18,900	$81.50	$1,540,350.00
1/2/2014	Elisha Finney	CFO	Sell	24,321	$77.69	$1,889,498.49
1/2/2014	Richard Levy	Director	Sell	20,000	$77.68	$1,553,600.00
12/30/2013	John Kuo	SVP	Sell	3,027	$77.08	$233,321.16
12/23/2013	Clarence Verhoef	SVP	Sell	1,297	$76.13	$98,740.61
12/9/2013	Dow Wilson	CEO	Sell	95,000	$79.09	$7,513,550.00
12/4/2013	Robert Kluge	SVP	Sell	12,932	$80.00	$1,034,560.00
12/2/2013	Elisha Finney	CFO	Sell	10,000	$79.04	$790,400.00
12/2/2013	Richard Levy	Director	Sell	20,000	$79.04	$1,580,800.00
12/2/2013	Robert Kluge	SVP	Sell	9,889	$79.00	$781,231.00
11/29/2013	Kolleen Kennedy	SVP	Sell	9,307	$78.00	$725,946.00
11/25/2013	Kolleen Kennedy	SVP	Sell	2,972	$75.49	$224,356.28
11/22/2013	Elisha Finney	CFO	Sell	1,617	$74.83	$121,000.11
11/14/2013	Elisha Finney	CFO	Sell	5,000	$74.95	$374,750.00
11/1/2013	Elisha W Finney	CFO	Sell	5,000	$72.27	$361,350.00
11/1/2013	Richard M Levy	Director	Sell	20,000	$72.27	$1,445,400.00
10/14/2013	Robert Kluge	SVP	Sell	13,889	$78.00	$1,083,342.00
10/10/2013	Robert Kluge	SVP	Sell	13,871	$77.00	$1,068,067.00
9/20/2013	Kolleen Kennedy	SVP	Sell	1,247	$76.00	$94,772.00
9/16/2013	Elisha Finney	CFO	Sell	16,334	$74.95	$1,224,233.30
9/16/2013	Kolleen Kennedy	SVP	Sell	2,562	$75.00	$192,150.00
9/11/2013	Elisha W Finney	CFO	Sell	23,666	$74.95	$1,773,766.70
9/3/2013	Elisha Finney	CFO	Sell	5,000	$70.95	$354,750.00
9/3/2013	Richard Levy	Director	Sell	20,000	$70.95	$1,419,000.00
8/8/2013	Kolleen Kennedy	SVP	Sell	2,400	$73.50	$176,400.00
8/1/2013	Elisha W Finney	CFO	Sell	5,000	$72.81	$364,050.00
8/1/2013	R Andrew Eckert	Director	Sell	1,375	$72.93	$100,278.75
7/19/2013	John W Kuo	SVP	Sell	1,817	$72.00	$130,824.00
7/17/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
7/16/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
6/17/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
6/17/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
6/10/2013	Timothy E Guertin	Director	Sell	27,000	$68.81	$1,857,870.00
5/21/2013	Elisha W Finney	CFO	Sell	2,313	$69.86	$161,586.18
5/14/2013	Elisha W Finney	CFO	Sell	5,000	$69.95	$349,750.00
5/14/2013	John W Kuo	SVP	Sell	1,112	$70.00	$77,840.00
5/14/2013	Richard M Levy	Director	Sell	20,000	$70.00	$1,400,000.00
2/14/2013	John W Kuo	SVP	Sell	1,111	$71.05	$78,936.55
9/4/2012	Kolleen T Kennedy	SVP	Sell	1,900	$64.00	$121,600.00
8/20/2012	Elisha W Finney	CFO	Sell	4,000	$59.95	$239,800.00

(Data available from 1/1/2013 forward)

Headline Trends for Varian Medical Systems (NYSE:VAR) Latest Headlines for Varian Medical Systems (NYSE:VAR)

Source:

Date	Headline
	Varian Announces Penn Medicine Treats World's First Patient on Halcyon System finance.yahoo.com - September 23 at 10:38 AM
	Form 4/A VARIAN MEDICAL SYSTEMS For: Sep 12 Filed by: KENNEDY KOLLEEN T www.streetinsider.com - September 20 at 10:49 AM
	Varian Ranks First in Overall Manufacturer, System, and Service Performance in 2017 Survey of Radiation Oncology Professionals finance.yahoo.com - September 20 at 10:49 AM
	Varian Medical (VAR) Releases FDA-Approved Eclipse 15.5 www.zacks.com - September 19 at 9:15 AM
	Varian Expands Clinicians' Cancer-fighting Toolkit with Eclipse 15.5 finance.yahoo.com - September 19 at 9:15 AM
	Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017 finance.yahoo.com - September 19 at 9:15 AM
	Varian Conducts Clinical Workshop, Strengthens Algeria Hold www.zacks.com - September 18 at 7:45 AM
	Notable Friday Option Activity: VAR, GD, DAR - Nasdaq www.nasdaq.com - September 15 at 3:41 PM
	Varian Holds First Clinical Workshop at New Algeria Facility finance.yahoo.com - September 15 at 11:00 AM
	Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 933 Shares of Stock www.americanbankingnews.com - September 14 at 4:32 PM
	Varian Medical Systems, Inc. (VAR) Expected to Post Earnings of $1.19 Per Share www.americanbankingnews.com - September 14 at 6:28 AM
	Form 4 VARIAN MEDICAL SYSTEMS For: Sep 12 Filed by: KENNEDY KOLLEEN T www.streetinsider.com - September 14 at 1:26 AM
	CONMED Corporation (CNMD) Ex-Dividend Date Scheduled for September 14, 2017 - Nasdaq www.nasdaq.com - September 13 at 8:23 PM
	Varian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 1,088 Shares www.americanbankingnews.com - September 13 at 4:34 PM
	Varian Medical Systems, Inc. (VAR) Downgraded by BTIG Research www.americanbankingnews.com - September 10 at 8:24 AM
	Dow R. Wilson Sells 15,059 Shares of Varian Medical Systems, Inc. (VAR) Stock www.americanbankingnews.com - September 8 at 4:22 PM
	Benzinga's Top Upgrades, Downgrades For September 7, 2017 - Benzinga www.benzinga.com - September 7 at 10:45 AM
	Varian Medical Systems, Inc. (VAR) Receives Consensus Rating of "Hold" from Analysts www.americanbankingnews.com - September 6 at 10:58 PM
	Varian Medical Systems, Inc. (VAR) Rating Reiterated by Royal Bank Of Canada www.americanbankingnews.com - September 2 at 7:34 AM
	Contrasting Varian Medical Systems (VAR) & Hologic (HOLX) www.americanbankingnews.com - September 1 at 10:12 PM
	Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 931 Shares of Stock www.americanbankingnews.com - September 1 at 4:20 PM
	Varian Medical Systems, Inc. (VAR) Rating Reiterated by Robert W. Baird www.americanbankingnews.com - August 28 at 12:00 PM
	Varian Medical Systems, Inc. (VAR) Expected to Post Quarterly Sales of $741.71 Million www.americanbankingnews.com - August 28 at 1:50 AM
	Zacks: Analysts Anticipate Varian Medical Systems, Inc. (VAR) Will Post Earnings of $1.19 Per Share www.americanbankingnews.com - August 26 at 8:16 PM
	Varian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor ... - PR Newswire (press release) www.prnewswire.com - August 26 at 5:24 AM
	Varian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor Events finance.yahoo.com - August 25 at 12:14 PM
	ETFs with exposure to Varian Medical Systems, Inc. : August 21, 2017 finance.yahoo.com - August 23 at 1:25 PM
	Varian Medical Systems, Inc. breached its 50 day moving average in a Bullish Manner : VAR-US : August 23, 2017 finance.yahoo.com - August 23 at 1:25 PM
	Varian Medical Systems’ Recent Stock Performance finance.yahoo.com - August 17 at 9:00 AM
	Head-To-Head Contrast: Varian Medical Systems (VAR) versus ABIOMED (ABMD) www.americanbankingnews.com - August 17 at 4:50 AM
	Kolleen T. Kennedy Sells 1,088 Shares of Varian Medical Systems, Inc. (VAR) Stock www.americanbankingnews.com - August 15 at 10:24 PM
	Varian’s Oncology Business Grows in Emerging Markets finance.yahoo.com - August 15 at 3:35 PM
	Varian’s Halcyon Treatment System Sees Emerging Market Demand finance.yahoo.com - August 15 at 3:35 PM
	Varian Medical Systems to Hold Investor Meeting at ASTRO in San Diego finance.yahoo.com - August 15 at 7:59 AM
	Why Varian Medical Systems’ Profitability Is Improving finance.yahoo.com - August 15 at 7:59 AM
	Varian Medical Systems, Inc. (VAR) Rating Increased to Hold at BidaskClub www.americanbankingnews.com - August 12 at 7:54 AM
	Pro-Trader Daily: Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators www.finanznachrichten.de - August 11 at 8:47 PM
	See what the IHS Markit Score report has to say about Varian Medical Systems Inc. finance.yahoo.com - August 11 at 3:43 PM
	Varian Announces New VP of Investor Relations - PR Newswire (press release) www.prnewswire.com - August 10 at 8:35 PM
	Varian Medical (VAR) Signs Distribution Deal with Bionix - Nasdaq www.nasdaq.com - August 10 at 8:35 PM
	Varian Medical (VAR) Signs Distribution Deal with Bionix finance.yahoo.com - August 10 at 3:31 PM
	Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q3, 2017 By the Numbers : August 10, 2017 finance.yahoo.com - August 10 at 3:31 PM
	Zacks: Analysts Expect Varian Medical Systems, Inc. (VAR) Will Announce Quarterly Sales of $741.71 Million www.americanbankingnews.com - August 10 at 2:38 PM
	Varian Announces New VP of Investor Relations finance.yahoo.com - August 10 at 9:20 AM
	First Patient Treated with Varian HyperArc High Definition Radiotherapy finance.yahoo.com - August 9 at 8:50 AM
	Varian Medical Systems Signs Brachytherapy Applicator Distribution Agreement with Bionix Radiation Therapy finance.yahoo.com - August 9 at 8:49 AM
	Dow R. Wilson Sells 15,059 Shares of Varian Medical Systems, Inc. (NYSE:VAR) Stock www.americanbankingnews.com - August 8 at 10:28 PM
	Varian Medical Systems, Inc. (NYSE:VAR) Expected to Announce Earnings of $1.19 Per Share www.americanbankingnews.com - August 8 at 10:22 AM
	Earnings Review and Free Research Report: Varian Medical Systems Reported Better than Expected Earnings finance.yahoo.com - August 7 at 8:03 AM
	Varian Medical Systems, Inc. (VAR) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - August 3 at 1:12 PM